About BG Medicine
BG Medicine is a company based in Waltham (United States) founded in 2000.. BG Medicine has raised $42.6 million across 5 funding rounds from investors including Humana, General Electric and Flagship Pioneering. The company has 3 employees as of December 31, 2022. BG Medicine operates in a competitive market with competitors including SphingoTec, Pronota, Critical Diagnostics, Upstream Medical Technologies and CorPatch, among others.
- Headquarter Waltham, United States
- Employees 3 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Bg Medicine Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$42.6 M (USD)
in 5 rounds
-
Latest Funding Round
$500 K (USD), Post-IPO
May 12, 2015
-
Investors
Humana
& 4 more
-
Employee Count
3
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of BG Medicine
BG Medicine is a publicly listed company on the OTC with ticker symbol BGMD in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of BG Medicine
BG Medicine has successfully raised a total of $42.6M across 5 strategic funding rounds. The most recent funding activity was a Post-IPO round of $500 thousand completed in May 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Post-IPO — $500,000
-
First Round
First Round
(01 Jul 2008)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2015 | Amount | Debt – Conventional - BG Medicine | Valuation |
investors |
|
| May, 2015 | Amount | Post-IPO - BG Medicine | Valuation |
investors |
|
| Mar, 2012 | Amount | Debt – Conventional - BG Medicine | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in BG Medicine
BG Medicine has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Humana, General Electric and Flagship Pioneering. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are invested in by this private equity firm.
|
Founded Year | Domain | Location | |
|
Private equity and venture captial firm focused on healthcare sectors
|
Founded Year | Domain | Location | |
|
Life sciences-focused venture capital firm
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BG Medicine
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - BG Medicine
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bg Medicine Comparisons
Competitors of BG Medicine
BG Medicine operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SphingoTec, Pronota, Critical Diagnostics, Upstream Medical Technologies and CorPatch, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biomarker-based diagnostic solutions for cancer and cardiovascular diseases are developed.
|
|
| domain | founded_year | HQ Location |
Diagnostics for heart failure, pre-eclampsia, and sepsis are provided.
|
|
| domain | founded_year | HQ Location |
Biomarkers-based tests for cardiovascular disease diagnostics are developed.
|
|
| domain | founded_year | HQ Location |
Patented cardiac biomarkers are developed for heart disease diagnostics.
|
|
| domain | founded_year | HQ Location |
Offers CPR feedback devices and apps for effective training and assistance during emergencies.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Bg Medicine
Frequently Asked Questions about BG Medicine
When was BG Medicine founded?
BG Medicine was founded in 2000 and raised its 1st funding round 8 years after it was founded.
Where is BG Medicine located?
BG Medicine is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.
Is BG Medicine a funded company?
BG Medicine is a funded company, having raised a total of $42.6M across 5 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $15M, raised on Jul 01, 2008.
How many employees does BG Medicine have?
As of Dec 31, 2022, the latest employee count at BG Medicine is 3.
What does BG Medicine do?
BG Medicine was founded in 2000 and is headquartered in Waltham, United States. Operations focus on the healthcare sector, where diagnostic tests for cardiovascular disorders, particularly heart failure, are developed. The Galectin-3 test is commercialized as an in vitro diagnostic ELISA assay to measure blood levels and provide prognosis for chronic heart failure patients. Distribution occurs through medical channels in the United States.
Who are the top competitors of BG Medicine?
BG Medicine's top competitors include SphingoTec, Upstream Medical Technologies and Critical Diagnostics.
Is BG Medicine publicly traded?
Yes, BG Medicine is publicly traded on OTC under the ticker symbol BGMD.
Who are BG Medicine's investors?
BG Medicine has 5 investors. Key investors include Humana, General Electric, Flagship Pioneering, GE Capital Canada, and Gilde Healthcare.
What is BG Medicine's ticker symbol?
The ticker symbol of BG Medicine is BGMD on OTC.